Search Results
Therapeutic targeting of TREM2 in Alzheimer’s disease
TREM2 as a target for disease modification in Alzheimer’s disease
TREM2-targeted antibodies enhance microglial function in Alzheimer’s disease model
Alzheimer Europe Conference, Angela Hodges, PHAGO - Targeting TREM2 & CD33 for treatment of AD
TREM2 (Triggering Receptor Expressed On Myeloid Cells-2) - Alzheimer's Disease
Future of tau-targeting immunotherapies in Alzheimer’s disease
Andrea Tenner - Inflammation as a Therapeutic Target in Alzheimer's Disease
Unleashing the potential of microglia as a therapeutic target
Studying the role of TREM2 in Alzheimer’s using stem cells – Dr Pablo Garcia Reitboeck
Targeting a new therapy for Alzheimer's
What’s the future of Alzheimer’s disease therapeutics?
Microglia in Alzheimer’s disease: evidence from genomics and transcriptomics